328 related articles for article (PubMed ID: 16393302)
21. Efficacy of H2 receptor antagonists for prevention of upper gastrointestinal bleeding during dual-antiplatelet therapy.
Yasu T; Sato N; Kurokawa Y; Saito S; Shoji M
Int J Clin Pharmacol Ther; 2013 Nov; 51(11):854-60. PubMed ID: 24040853
[TBL] [Abstract][Full Text] [Related]
22. Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention.
Tan VP; Yan BP; Kiernan TJ; Ajani AE
Cardiovasc Revasc Med; 2009; 10(1):36-44. PubMed ID: 19159853
[TBL] [Abstract][Full Text] [Related]
23. [Upper gastrointestinal bleeding in patients treated by low-dose aspirin].
Capet C; Czernichow P; Dupas JL; Goria O; Gouérou H; Hochain P; Amouretti M; Herman H; Colin R
Gastroenterol Clin Biol; 2001 Mar; 25(3):233-8. PubMed ID: 11395668
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleed.
Schreiner GC; Laine L; Murphy SA; Cannon CP
Crit Pathw Cardiol; 2007 Dec; 6(4):169-72. PubMed ID: 18091407
[TBL] [Abstract][Full Text] [Related]
25. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture.
Vestergaard P; Rejnmark L; Mosekilde L
Calcif Tissue Int; 2006 Aug; 79(2):76-83. PubMed ID: 16927047
[TBL] [Abstract][Full Text] [Related]
26. [Risk and prevention of gastrointestinal complications due to low-dose aspirin and other antiplatelet agents].
Bretagne JF
Rev Prat; 2008 Sep; 58(13):1434-6, 1439-40. PubMed ID: 18924327
[TBL] [Abstract][Full Text] [Related]
27. Optimal drug therapy after aspirin-induced upper gastrointestinal bleeding.
Struijk M; Postma DF; van Tuyl SA; van de Ree MA
Eur J Intern Med; 2012 Apr; 23(3):227-30. PubMed ID: 22385878
[TBL] [Abstract][Full Text] [Related]
28. Proton pump inhibitors are associated with lower gastrointestinal tract bleeding in low-dose aspirin users with ischaemic heart disease.
Miyake K; Akimoto T; Hanada Y; Nagoya H; Kodaka Y; Ueki N; Kusunoki M; Kawagoe T; Futagami S; Takahashi Y; Takano H; Sakamoto C
Dig Liver Dis; 2015 Sep; 47(9):757-62. PubMed ID: 26105589
[TBL] [Abstract][Full Text] [Related]
29. The interaction between proton pump inhibitors and clopidogrel and upper gastrointestinal bleeding.
Leontiadis GI; Yuan Y; Howden CW
Gastrointest Endosc Clin N Am; 2011 Oct; 21(4):637-56. PubMed ID: 21944415
[TBL] [Abstract][Full Text] [Related]
30. Upper gastrointestinal bleeding in patients with aspirin and clopidogrel co-therapy.
Ng FH; Lam KF; Wong SY; Chang CM; Lau YK; Yuen WC; Chu WM; Wong BC
Digestion; 2008; 77(3-4):173-7. PubMed ID: 18577887
[TBL] [Abstract][Full Text] [Related]
31. Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleeding.
Sáez ME; González-Pérez A; Johansson S; Nagy P; García Rodríguez LA
Am J Cardiovasc Drugs; 2014 Dec; 14(6):443-50. PubMed ID: 25119521
[TBL] [Abstract][Full Text] [Related]
32. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
[TBL] [Abstract][Full Text] [Related]
33. Gastrointestinal bleeding in the setting of anticoagulation and antiplatelet therapy.
Barada K; Abdul-Baki H; El Hajj II; Hashash JG; Green PH
J Clin Gastroenterol; 2009 Jan; 43(1):5-12. PubMed ID: 18607297
[TBL] [Abstract][Full Text] [Related]
34. Does clopidogrel rather than aspirin plus a proton-pump inhibitor reduce the frequency of gastrointestinal complications after cardiac surgery?
Ziegelin M; Hoschtitzky A; Dunning J; Hooper T
Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):534-7. PubMed ID: 17669930
[TBL] [Abstract][Full Text] [Related]
35. Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan.
Nadatani Y; Watanabe T; Tanigawa T; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Yoshiyama M; Arakawa T
Scand J Gastroenterol; 2013 Mar; 48(3):320-5. PubMed ID: 23298342
[TBL] [Abstract][Full Text] [Related]
36. Lower GI bleeding is more common than upper among patients on dual antiplatelet therapy: long-term follow-up of a cohort of patients commonly using PPI co-therapy.
Casado Arroyo R; Polo-Tomas M; Roncalés MP; Scheiman J; Lanas A
Heart; 2012 May; 98(9):718-23. PubMed ID: 22523056
[TBL] [Abstract][Full Text] [Related]
37. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants.
Lanas Á; Carrera-Lasfuentes P; Arguedas Y; García S; Bujanda L; Calvet X; Ponce J; Perez-Aísa Á; Castro M; Muñoz M; Sostres C; García-Rodríguez LA
Clin Gastroenterol Hepatol; 2015 May; 13(5):906-12.e2. PubMed ID: 25460554
[TBL] [Abstract][Full Text] [Related]
38. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study.
Hallas J; Dall M; Andries A; Andersen BS; Aalykke C; Hansen JM; Andersen M; Lassen AT
BMJ; 2006 Oct; 333(7571):726. PubMed ID: 16984924
[TBL] [Abstract][Full Text] [Related]
39. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
Diener HC
Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
[TBL] [Abstract][Full Text] [Related]
40. The safety of endoscopic sphincterotomy in patients receiving antiplatelet agents: a case-control study.
Hussain N; Alsulaiman R; Burtin P; Toubouti Y; Rahme E; Boivin JF; Barkun AN
Aliment Pharmacol Ther; 2007 Mar; 25(5):579-84. PubMed ID: 17305758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]